Ken Griffin’s Aethlon Medical AEMD Stock Holding History

Ken Griffin’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9	Closed	-$69K	–	13469
2021 Q4	$69K	Sell	9 -2	-18%	-$22.8K	﹤0.01%	13036
2021 Q3	$171K	Buy	+11	New	+$185K	﹤0.01%	12193

Other funds holding AEMD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Ken Griffin's AEMD Position: Q4 2025 in Review

Ken Griffin sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 1,902 shares — an estimated $71.2K sold.

Ken Griffin first reported a position in AEMD in Q2 2019 and held it in 6 quarters. The position peaked at $72K in Q3 2022. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

Ken Griffin reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
Ken Griffin sold 1,902 Aethlon Medical shares in Q4 2025, an estimated $71.2K.
Ken Griffin first reported a position in Aethlon Medical in Q2 2019 and held it in 6 quarters.
Ken Griffin's Aethlon Medical position peaked at $72K in Q3 2022.
7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.